CD79A and neoplasm: While lymphoid aggregates alone did not distinguish between responsive and non-responsive tumours, the integrated analysis revealed higher expression of genes like CD37, MS4A1, BLK, CD79A/B, and TNFRSF13C in responsive tumours’ lymphoid aggregates.